Top Markets
Coin of the day
BetterLife Pharma Inc. BetterLife Pharma Inc.

BetterLife Pharma Inc.

BETR
주식 순위 #26463
BetterLife Pharma Inc. is a biotechnology company focused on the global... BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary interferon-based technologies, designed to engage the immune system in combating viral infections. Its active development pipeline includes BETR-001, intended for major depressive disorder, treatment-resistant depression, cluster headaches, and post-traumatic stress disorder. Another key asset, BETR-002, is being advanced to address benzodiazepine dependency, anxiety, and spasticity. Further in development are MM-003 for COVID-19 and other respiratory viral infections; MM-001, a topical intravaginal cream for HPV-induced cervical intraepithelial neoplasia; and AP-002, designated for cancer treatment. BetterLife Pharma Inc. maintains a research collaboration with the University of California San Diego, focusing on preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. Headquartered in Vancouver, Canada, the company was founded in 2002 and was formerly known as Pivot Pharmaceuticals Inc. before adopting the name BetterLife Pharma Inc. in December 2019.
주가
$0.24953854
시가총액
$40.40M
변동 (1일)
-2.86%
변동 (1년)
307.27%
국가
CA
거래 BetterLife Pharma Inc. (BETR)

카테고리

BetterLife Pharma Inc. (BETR)의 주가 이력
최고 종가: $0.24 (2026-08-01 기준)

최저 종가: $16.33 (2017-12-01 기준)
BetterLife Pharma Inc.의 주가 이력 (2017 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 61.70%
2025 -48.63%
2024 64.06%
2023 -63.38%
2022 -28.33%
2021 -81.89%
2020 -10.45%
2019 -57.04%
2018 -84.52%
2017 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$540.74 37.12%
US
$1.03K 56.13%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$131.96 390.74%
US